Browse > Article

Mass expression of Apx I and Apx II of Actinobacillus pleuropneumoniae in Escherichia coli  

Kim, Tae-Jung (College of Veterinary Medicine, Chonnam National University)
Lee, Bong-Joo (College of Veterinary Medicine, Chonnam National University)
Lee, Jae-Il (College of Veterinary Medicine, Chonnam National University)
Publication Information
Korean Journal of Veterinary Research / v.45, no.2, 2005 , pp. 185-189 More about this Journal
Abstract
Actinobacillus pleuropneumoniae is the causative agent of a porcine contagious pleuropneumonia. Among several virulence factors including exotoxin (Apx toxins), LPS, transferrin-binding proteins, OMPs, and some proteases, Apx toxins have been major targets for the protection study. In this study, cloning and expression of A. pleuropneumoniae Apx I and Apx II toxin, which are produced by all highly virulent strains, were performed by Escherichia coli expression system. Genes coding Apx I and II toxin were amplified from the A. pleuropneumoniae serotype 5 genomic DNA using polymerase chain reaction and cloned to a prokaryotic expression vector, pRSET. Expression of the Apx I and Apx II coding sequences in E. coli resulted in the formation of insoluble inclusion bodies purified according to a denaturing purification protocol, which employs the use of guanidium. Recombinant proteins were purified using $Ni^{2+}$-charged resin affinity purification. This expression and purification system made it possible to produce Apx I and Apx II in large amounts for further immunologic studies.
Keywords
Actinobacillus pleuropneumoniae; Apx toxin; recombinant protein expression;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology. Wiley, New York, 1996
2 Bosse JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, Landford PR. A. pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect 2002, 4, 225-235   DOI   ScienceOn
3 Chiers K, van Overbeke I, de Laender P, Ducatelle R, Carel S, Haesebrouck F. Effects of endothelial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins. Vet Q 1998, 20, 65-69   DOI   ScienceOn
4 Kamp EM, Stockhofe-Zurwieden N, van Leengoed LAMG, Smits MA. Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs. Infect Immun 1997, 65, 4350-4354
5 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989
6 신성재, 조영욱, 유한상. 국내분리 흉막폐렴균의 apxIA, IIA, IIA 유전자 cloning, 염기서열 분석 및 단백질 발현. 대한수의학회지 2003, 43, 247-253
7 Prideaux CT, Lenghaus C, Krywult J, Hodgson ALM. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the Apx II operon. Infect Immun 1999, 67, 1962-1966
8 Jarma E, Corradino G, Regassa LB. Anaerobiosis, growth phase and Actinobacillus pleuropneumoniae RTX toxin production. Microb Pathog 2004, 37, 29-33   DOI   ScienceOn
9 Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol 1995, 3, 257-261   DOI   PUBMED   ScienceOn
10 Van den Bosch H, Frey J. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. Vaccine 2003, 21, 3601-3607   DOI   ScienceOn
11 Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R, Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 2004, 100, 255-268   DOI   PUBMED   ScienceOn
12 Chiers K, Donne E, van Overbeke I, Ducatelle R, Haesebrouck F. Actinobacillus pleuropneumoniae infections in closed swine herds: infection patterns and serological profiles. Vet Microbiol 2002, 85, 343-352   DOI   ScienceOn
13 Burdychova R, Rychtera M, Horvath R, Dendis M, Bartos M. Expression of Actinobacillus pleuropneumoniae gene coding for Apx I protein in Escherichia coli. FEMS Microbiol Lett 2004, 230, 9-12   DOI   ScienceOn
14 Van Overbeke I, Chiers K, Donne E, Ducatelle R, Haesebrouck F. Effects of endothelial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and tranferrin-binding proteins. J Vet Med B 2001, 48, 15-20   DOI   ScienceOn
15 Seah JN, Frey J, Kwang J. The N-terminal domain of RTX toxin Apx I of Actinobacillus pleuropneumoniae elicits protective immunity in mice. Infect Immun 2002, 70, 6464-6467   DOI   ScienceOn
16 Haesebrouck F, Chiers K, van Overbeke I, Ducatelle R. A. pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 1997, 58, 239-249   DOI   ScienceOn